Oppenheimer lowered the firm’s price target on Community Health to $4.50 from $5.50 and keeps an Outperform rating on the shares following quarterly results. The firm notes Community Health maintained its 2024 outlook. Overall, at these levels, Oppenheimer continues to see attractive upside for long-term investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CYH:
- Community Health Q1 2024 Earnings and Business Update
- CYH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Community Health to sell Cleveland, Tennessee, hospital for $160M
- Hospital survey weakened ‘dramatically’ in March, says TD Cowen
- Community Health initiated with an Equal Weight at Barclays